92
Views
32
CrossRef citations to date
0
Altmetric
Drug Evaluation

Ziprasidone: a new atypical antipsychotic

, &
Pages 1033-1042 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Pietro Gareri, Cristina Segura-García, Valeria Graziella Laura Manfredi, Antonella Bruni, Paola Ciambrone, Gregorio Cerminara, Giovambattista De Sarro & Pasquale De Fazio. (2014) Use of atypical antipsychotics in the elderly: a clinical review. Clinical Interventions in Aging 9, pages 1363-1373.
Read now
Daniel Huys, Katja Hardenacke, Pia Poppe, Christina Bartsch, Burak Baskin & Jens Kuhn. (2012) Update on the role of antipsychotics in the treatment of Tourette syndrome. Neuropsychiatric Disease and Treatment 8, pages 95-104.
Read now
Nick C Patel & Paul E Keck Jr. (2006) Ziprasidone: efficacy and safety in patients with bipolar disorder. Expert Review of Neurotherapeutics 6:8, pages 1129-1138.
Read now
Yavuz S Silay & Joseph Jankovic. (2005) Emerging drugs in Tourette syndrome. Expert Opinion on Emerging Drugs 10:2, pages 365-380.
Read now
Philip D Harvey & Christopher R Bowie. (2005) Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness. Expert Opinion on Pharmacotherapy 6:2, pages 337-346.
Read now
Stephen M Strakowski, Melissa P Del Bello, Caleb M Adler & Paul E Keck Jr. (2003) Atypical antipsychotics in the treatment of bipolar disorder. Expert Opinion on Pharmacotherapy 4:5, pages 751-760.
Read now
Paul E Keck Jr & Susan L McElroy. (2003) Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic. Expert Opinion on Investigational Drugs 12:4, pages 655-662.
Read now
Gina Kuperberg, Robert Kerwin & Robin Murray. (2002) Developments in the pharmacological treatment of schizophrenia. Expert Opinion on Investigational Drugs 11:10, pages 1335-1341.
Read now
Gary Remington. (2002) ‘Atypical’ antipsychotics: where does ziprasidone fit?. Expert Review of Neurotherapeutics 2:1, pages 13-24.
Read now

Articles from other publishers (23)

Hao Gong, Xiangyu Du, Anping Su & Yaowu Du. (2023) Pharmacological treatment of Tourette’s syndrome: from the past to the future. Neurological Sciences.
Crossref
Keisuke Ueda & Kevin J. Black. (2021) A Comprehensive Review of Tic Disorders in Children. Journal of Clinical Medicine 10:11, pages 2479.
Crossref
Hasan, Zaidi, Nirwan, Ghori, Javid, Ahmadi & Babar. (2019) Use of Central Nervous System (CNS) Medicines in Aged Care Homes: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 8:9, pages 1292.
Crossref
Se Joo Kim. (2018) Pharmacological Treatment Strategies for Acute Bipolar Depression. Journal of Korean Neuropsychiatric Association 57:4, pages 287.
Crossref
Thomas L. Schwartz & Stephen M. Stahl. (2011) Treatment Strategies for Dosing the Second Generation Antipsychotics. CNS Neuroscience & Therapeutics 17:2, pages 110-117.
Crossref
Anne F. Gross & Kathy M. Sanders. 2008. Massachusetts General Hospital Comprehensive Clinical Psychiatry. Massachusetts General Hospital Comprehensive Clinical Psychiatry 895 905 .
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Xavier Pi-Sunyer, Louis Aronne & George Bray. (2007) Weight Gain Induced by Psychotropic Drugs. Obesity Management 3:4, pages 165-169.
Crossref
Anna Maria Nicolai Costa, Mauricio Silva de Lima, Marité Faria, Salomão Rodrigues Filho, Irismar Reis De Oliveira & Jair de Jesus Mari. (2016) A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia. Journal of Psychopharmacology 21:2, pages 165-170.
Crossref
Patricia A Marken & Ronald W Pies. (2016) Emerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles. Annals of Pharmacotherapy 40:2, pages 276-285.
Crossref
Pietro Gareri, Pasquale De Fazio, Salvatore De Fazio, Norma Marigliano, Guido Ferreri Ibbadu & Giovambattista De Sarro. (2006) Adverse Effects of Atypical Antipsychotics in the Elderly. Drugs & Aging 23:12, pages 937-956.
Crossref
R. Scott Obach & Robert L. Walsky. (2005) Drugs That Inhibit Oxidation Reactions Catalyzed by Aldehyde Oxidase Do Not Inhibit the Reductive Metabolism of Ziprasidone to its Major Metabolite, S-Methyldihydroziprasidone. Journal of Clinical Psychopharmacology 25:6, pages 605-608.
Crossref
Valérie J. Fedorowicz & Eric Fombonne. (2016) Metabolic side effects of atypical antipsychotics in children: a literature review. Journal of Psychopharmacology 19:5, pages 533-550.
Crossref
David L Dunner. (2005) Safety and tolerability of emerging pharmacological treatments for bipolar disorder. Bipolar Disorders 7:4, pages 307-325.
Crossref
G. S. Malhi, M. Berk, M. Bourin, B. Ivanovski, S. Dodd, J. Lagopoulos & P. B. Mitchell. (2005) Atypical mood stabilizers: a 'typical' role for atypical antipsychotics. Acta Psychiatrica Scandinavica 111:s426, pages 29-38.
Crossref
Sanjay Gupta, Prakash S Masand, Shubdeep Virk, Thomas Schwartz, Ahmed Hameed, Bradford L Frank & Kari Lockwood. (2004) Weight decline in patients switching from olanzapine to quetiapine. Schizophrenia Research 70:1, pages 57-62.
Crossref
Christoph Hiemke, Aleksandra Dragicevic, Gerhard Gründer, Sebastian Hätter, Julia Sachse, Ingo Vernaleken & Matthias J. Müller. (2004) Therapeutic Monitoring of New Antipsychotic Drugs. Therapeutic Drug Monitoring 26:2, pages 156-160.
Crossref
Henry W.M. Kwok. (2003) Psychopharmacology in autism spectrum disorders. Current Opinion in Psychiatry 16:5, pages 529-534.
Crossref
MICHAEL J. LABELLARTE, MARK A. RIDDLE & JANE E. CROSSON. (2003) The Relevance of Prolonged QTc Measurement to Pediatric Psychopharmacology. Journal of the American Academy of Child & Adolescent Psychiatry 42:6, pages 642-650.
Crossref
Neil S. Kaye. (2003) Psychic Akathisia. Journal of Clinical Psychopharmacology 23:2, pages 206.
Crossref
Elie Paul Elovic, Ramon Lansang, Yali Li & Joseph H. Ricker. (2003) The Use of Atypical Antipsychotics in Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 18:2, pages 177-195.
Crossref
Pietro Gareri, Pasquale De Fazio, Mariagrazia Stilo, Guido Ferreri & Giovambattista De Sarro. (2003) Conventional and Atypical Antipsychotics in the Elderly. Clinical Drug Investigation 23:5, pages 287-322.
Crossref
J. Bobes, J. Rejas, M. Garcia-Garcia, F. Rico-Villademoros, M.P. Garc??a-Portilla, M. Madrigal & G. Hern??ndez. (2002) Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol. Clinical Drug Investigation 22:9, pages 609-622.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.